Form 8-K - Current report:
SEC Accession No. 0001564590-20-053015
Filing Date
2020-11-10
Accepted
2020-11-10 16:40:14
Documents
3
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-8k_20201110.htm 8-K 32194
2 EX-99.1 lyra-ex991_7.htm EX-99.1 237418
3 GRAPHIC gh5whxdiri1q000001.jpg GRAPHIC 168745
  Complete submission text file 0001564590-20-053015.txt   493949
Mailing Address 480 ARSENAL STREET WATERTOWN MA 02472
Business Address 480 ARSENAL STREET WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 201301726
SIC: 3841 Surgical & Medical Instruments & Apparatus